Delivery Order SPE2DB20D6035-SPE2DB25FLYHL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,011.75 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,414.81 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,663.10. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was awarded competitively without set-aside provisions, reflecting AmerisourceBergen's capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.04 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This non-competitive delivery order carries a firm fixed price arrangement and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a $4,855.20 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement, with an ultimate completion date of August 5, 2025. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,674.46. This award is issued as a firm fixed price delivery order with an ultimate completion date of June 25, 2025, and represents a non-competitive set-aside award. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Losartan Potassium 100 mg tablets (1,000 count) with a ceiling value of $2,257.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The delivery is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for 1,000 tablets of Losartan Potassium 100 mg at a ceiling value of $1,650.11. This is a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's ability to meet federal procurement...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB25FLYHLDelivery Order
AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) valued at $3,404.62 for 1,000 tablets of Losartan Potassium 25 mg, with a completion date of September 19, 2025. The contract was awarded on September 18, 2025, using firm fixed-price terms without set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The Losartan Potassium delivery represents one of numerous routine orders fulfilling the company's role as a critical pharmaceutical vendor for federal medical procurement, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/18/25 |